YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Summary

In order to reduce the clinical demand for kidney dialysis rate of Diabetic Kidney Disease（DKD） patients, a bidirectional cohort study of 4472 patients with DKD (Qi deficiency and collateral stasis syndrome) was carried out based on a preliminary DKD cohort of 13,000 patients. The exposure factor was supplementing and reducing the kidney turbidity-Huoxue Tongluo method represented by the addition and subversion of Shenzhuo prescription, and the incidence of end-stage renal disease was the main therapeutic index. Follow-up was conducted for 2 years

Conditions

• Diabetic Kidney Disease (DKD)

Sponsors & Collaborators

• Guang'anmen Hospital of China Academy of Chinese Medical Sciences

  collaborator OTHER

• First Affiliated Hospital, Sun Yat-Sen University

  collaborator OTHER

• Tianjin Medical University Chu Hsien-I Memorial Hospital

  collaborator UNKNOWN

• Changchun University of Chinese Medicine

  collaborator OTHER

• EFONG PHARMRCEUTICRL

  collaborator UNKNOWN

• Xinxiang Central Hospital of Henan province

  collaborator UNKNOWN

• Xiamen Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

  collaborator OTHER

• Beijing Tiantan Hospital

  collaborator OTHER

• Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine

  collaborator OTHER

• Hubei Zhongshan Hospital Affiliated to Wuhan University

  collaborator UNKNOWN

• Liu Hongfang

  lead OTHER

Principal Investigators

• HongFang Liu · Dongzhimen Hospital

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-08-01

Primary Completion

2028-07-31

Completion

2028-07-31

Countries

• China

Study Locations